A boutique investment firm that manages both wealth and private equity/VC in the healthcare sector.
About Lanx Capital
Lanx Capital is a Rio de Janeiro-based boutique investment firm managing both wealth and private equity and venture capital activity, with a healthcare-sector focus that distinguishes it from generalist Brazilian VCs. Stage focus is seed and Series A with checks in the $1M to $5M range, and AI is not flagged as a primary focus. Healthcare interest centers on care delivery, tech-enabled services, and digital health, with the firm’s wealth-management lineage giving it deeper relationships with Brazilian family offices and high-net-worth investors than most pure VCs. The right founder for Lanx is a Brazilian healthcare operator building a tech-enabled care delivery, digital health, or healthcare services business with real revenue, clear unit economics, and the operational sophistication to scale within Brazil’s complex public-private payer environment. The wrong founder is a pre-revenue pure software team without healthcare execution experience, a US-pedigreed founder using Brazil only as a satellite, or a deep medtech or therapeutics team needing scientific syndicate construction. Intro paths run through Rio and Sao Paulo’s healthcare operator networks including DASA, Hapvida, Dasa-Notre Dame Intermedica alumni, the Endeavor Brazil cohort, frequent co-investors and follow-on partners including DNA Capital, Kortex, Crescera Capital, and the broader Brazilian healthcare-focused PE community, and through Lanx’s wealth-management client network which is a distinctive intro vector. In the pitch, lead with audited or audit-ready financials, real revenue evidence, the use of proceeds tied to specific scaling levers, and a credible read on the operadoras de saude private payer landscape and the SUS public reality. Be specific about ANS, ANVISA, CFM, and LGPD regulatory posture, and about your operational model whether B2C, B2B2C through employers, or B2B with payer or provider customers. Show that you understand how the Bradesco, Hapvida, and SulAmerica payer dynamics shape your business. Caveats include the relatively concentrated portfolio approach which means Lanx is selective about its commitments, the Rio-based location which is less centrally connected to Sao Paulo’s broader VC scene, and the reality that boutique firms have variable follow-on capacity. For Brazilian healthcare founders with execution credentials, Lanx is a sector-focused partner with wealth-management relationships that other VCs cannot match.
Founder reviews
Other portfolio companies
Companies in Lanx Capital's portfolio not currently in our directory.
- Wildlife Studios
- Eneva
- re.green
Team
Pitch / review this investor
Have you raised from Lanx Capital? Founders only — share your honest experience (anonymous OK, moderated before publishing).